bioweapons

Information about bioweapons

Published on March 4, 2008

Author: Charlie

Source: authorstream.com

Content

Biological Weapons and Biotechnology: Briefing to the Out of the Box and Into the Future Conference:  Biological Weapons and Biotechnology: Briefing to the Out of the Box and Into the Future Conference David W. Siegrist Potomac Institute for Policy Studies Arlington, VA 22209 [email protected] June 27, 2000 Biological Weapons and Biotechnology:  Biological Weapons and Biotechnology Will Advanced Biotechnology more Favor Offense or Defense against Biological Weapons? Currently, Offense Far Outpaces Defense in Bioweapons DoD Questions Utility of Genetic Engineering of Weapons:  DoD Questions Utility of Genetic Engineering of Weapons Despite Prodigious Soviet Efforts, “Current BW Agents Do Not Represent a Significant, or Even Incremental Improvement Over What Was Available Decades Ago. This Fact Suggests That Nations With Current Programs, and Especially New Entrants, Will Find the “Classic” BW Agents Difficult to Improve.” Biotechnology and Genetic Engineering:  Implications for the Development of New Warfare Agents Slide4:  Anthrax (from DoD Website) “There is no effective treatment for inhalational anthrax. Antibiotics will suppress infection only if administered early after exposure -- usually within the first 24 - 48 hours. By the time symptoms develop, it is highly likely death will occur despite the best efforts of modern medical science. 99% lethal to unprotected individuals.” Anthrax Scenario:  Anthrax Scenario Limited Antibiotics and Vaccines Numerous “Worried Well” Sensors Cannot Detect Previous Open Air Aerosol Passage Non-Specific, Flu-Like Symptoms Potential for Civil Unrest, Lack of Faith in Authorities Need for Rapid (Pre-symptomatic) Diagnostics Need for Actual Cure for Inhalational Anthrax Some Possibilities to Disrupt Anthrax Pathogenesis:  Some Possibilities to Disrupt Anthrax Pathogenesis Prevent Anthrax Spore Germination Block Protective Antigen Binding to Host Cells Prevent Protease of Bound PA Neutralize Lethal Factor and Edema Factor Prevent Septicemia and Toxic Shock Prevent Secondary Hemorrhage in Lung Capillaries Some Possibilities to Disrupt Anthrax Pathogenesis:  Some Possibilities to Disrupt Anthrax Pathogenesis Prevent Anthrax Spore Germination DARPA Defense Sciences Office Program Block Protective Antigen Binding to Host Cells Small Molecules to Block CHO-K1 Cells Anthrax Molecular Receptor Decoys in Lymphatic System Prevent Protease of Bound PA Protease Inhibitor Neutralize Lethal Factor and Edema Factor Monoclonal Antibodies Prevent Septicemia and Toxic Shock Nitric Oxide Scavenger; Modulate Cytokines/Inflammation Cascade Lilly Medication in Phase III Test Prevent Secondary Hemorrhage in Lung Capillaries Fibrin Vasopressors for Hypotension Or, Back to the Future…? Bacteriophage Therapy:  Or, Back to the Future…? Bacteriophage Therapy Bacteriophages are Viruses that Prey on Bacteria Theoretically, Bacteriophage against Anthrax Might be Given to Cure Victims Germans in WWII had a Product against Shigella Antibiotics Lessened Interest in Bacteriophage Therapy Bacteriophages Can Survive in Bloodstream and Penetrate some Fibrous Defenses Currently Being Developed for MDR TB, VRE, MRSA Advanced Biotech Making What’s Old New Again Transition:  Transition Advanced Biotechnology Is Vital to Improving Biological Weapon Defense Although There Are Multiple Pathogens, the Ways They Damage Hosts Have Some Commonalities Targeting Common Disease Pathways May Help Overcome Current Offense/Defense Mismatch Biotech Supports Move to More Active Defense However, Biotechnology May Also Be Used by Weapon Developers Might It Also Assist Offense? Biotechnology Assistance to Offense? (Note: US Stopped Its Offensive Program in 1969):  Biotechnology Assistance to Offense? (Note: US Stopped Its Offensive Program in 1969) Improve Effectiveness of Existing Agents Create Different Kinds of Agents Proliferate Expertise and Tools The Population Capable of Creating Biological Agents Will Increase, Including “Bad Apples” Biotech Tools Will be Created to Routinize Complex Tasks Biological Weapon Characteristics From DoD 1997 “Genetics” Report:  Biological Weapon Characteristics From DoD 1997 “Genetics” Report Different Types of Bio Weapons The Soviet Biopreparat Example:  Different Types of Bio Weapons The Soviet Biopreparat Example Biopreparat: Up to 40K People Working for 20 Years Enhanced Anthrax “Super” Bubonic Plague Strategic Weapon for War with US Sought to Induce Its Resistance to Many Antibiotics Used Traditional Techniques (Vice Gene Splicing) “Chimera” Smallpox with Marburg/Ebola Virus Ken Alibek Contention Sought to Combine Stability and Infectivity of Smallpox with Lethality of Marburg/Ebola? Combination May Actually Reduce Lethality Behavior Modulators Endorphins. Others? Few Reported Results. Limited Results. Biotech Weapons Hard to Make. One Successful Ongoing Biotechnology Weapon Application:  One Successful Ongoing Biotechnology Weapon Application “’Advanced biological weapons techniques’ are already in use in agriculture with no restrictions - aerial spraying of recombinant baculoviruses containing the scorpion venom toxin gene” -- Floyd Horn, USDA Possible New Agent Type: Neuropeptides/Bioregulators:  Possible New Agent Type: Neuropeptides/Bioregulators Neuropeptides Mediate Many Bodily Functions May be Developed as Super Toxins or Behavior Modifiers They Regulate Reproduction, Metabolism, Growth, Temperature, Heart Rate, Eating, Drinking, Breathing, Behavior, Memory, Emotional State… May Act as Neurohormones, Neuromodulators, and/or Neurotransmittters Examples: Endorphins; Enkephalins; Tachykinins… Hard to Transit the Blood-Brain Barrier. Redundant Controls of Bodily Functions. Possibility to Change How People Are? “At Least Three of the Seven Deadly Sins Are Mediated by Neuropeptides” -- Charles F. Stevens Utility of Genetically Engineered Weapons?:  Utility of Genetically Engineered Weapons? Creating Bio Agents Just a First Step to a Weapon Actual Weaponization Requires Infrastructure, Extensive Testing Increases Organizational “Footprint” and Intelligence Signatures Increased Opportunities for Some Form of Intervention Attributability of a Biological Attack tends to Increase with Use of Advanced Biotechnology Relatively Few Have Capability for Sophisticated Attack Increase Traceability Back to State Sponsor, Other Presumptive Act of War Attributability Should Deter Potential State Sponsors Example Approaches for Advanced Bio Defense Need to Leverage Common Pathways Among Diseases:  Example Approaches for Advanced Bio Defense Need to Leverage Common Pathways Among Diseases Isis: Identified Several Common Pathogenic Portions of Bacteria and Small Molecule Lead Compounds to Bind Them May Be Useful Against Even Engineered Pathogens UVA: Heteropolymers to Link Red Cells and Decoy Receptors Developmental Antiviral Successful in Monkeys against Bio Agents Stanford U: Type 3 Secretion Pathway for Virulence Factors Inhibiting Pathway May Stop Transport of Toxic Proteins U Maine: Presymptomatic Diagnostics Through Nitric Oxide Exhaled NO Increases as Body Starts to Fight Disease U Texas: Monoclonal Antibodies with Immobilization Tails Create Hybrid “Immunoplastic” Biosensors Many Others. These Projects Are Listed as Examples of Possibilities. They Are Not Reduced to Practice. Conclusion:  Conclusion Defensive Advanced Biotechnology Is Critical to Mitigate Offense/Defense Mismatch in Biological Weapons High Utility also Against Emerging/Reemerging Diseases Biotech May Be Used by Some to Enhance Weapons Effects Note: US Offensive Program Stopped in 1969 Weapons Manufacture Harder than Many Think However, Risk of Their Use is Somewhat Mitigated by Operational Limitations to their Presumed Perceived Utility Net Benefit Accrues to Defense, Since It Is Already Far Behind The US and Its Allies Have an Asymmetric Advantage in Biotech We Need to Leverage to Overcome Asymmetric Biological Threats Slide18:  University of Virginia Heteropolymers

Related presentations


Other presentations created by Charlie

Personality Development
17. 11. 2007
0 views

Personality Development

History of Plastics
30. 04. 2008
0 views

History of Plastics

Juniper Networks 22 Nov 2005
28. 04. 2008
0 views

Juniper Networks 22 Nov 2005

CA Communications 02 20 08
18. 04. 2008
0 views

CA Communications 02 20 08

BharAloutlookISRI
17. 04. 2008
0 views

BharAloutlookISRI

direct basis
16. 04. 2008
0 views

direct basis

AnEconomicHistory English
14. 04. 2008
0 views

AnEconomicHistory English

Chap002
13. 04. 2008
0 views

Chap002

Financial Crisis
10. 04. 2008
0 views

Financial Crisis

NATO Today
23. 12. 2007
0 views

NATO Today

TM photo pp ppt
08. 10. 2007
0 views

TM photo pp ppt

2007 seminar 3
12. 10. 2007
0 views

2007 seminar 3

Roalddahl
12. 10. 2007
0 views

Roalddahl

micro credit presentation
15. 10. 2007
0 views

micro credit presentation

lecture 9 12 proteins 2007
16. 10. 2007
0 views

lecture 9 12 proteins 2007

Spanish American War
22. 10. 2007
0 views

Spanish American War

ppw 6 28 04
07. 10. 2007
0 views

ppw 6 28 04

PP2
23. 10. 2007
0 views

PP2

KATRINA TEACHERS GUIDEpr
04. 09. 2007
0 views

KATRINA TEACHERS GUIDEpr

ECA Knowledge Fair
31. 08. 2007
0 views

ECA Knowledge Fair

Automatic Indexing
31. 08. 2007
0 views

Automatic Indexing

ROLE OF JOURNALISTS UNION
31. 08. 2007
0 views

ROLE OF JOURNALISTS UNION

wendy
15. 11. 2007
0 views

wendy

Maximize Access Coverage
28. 11. 2007
0 views

Maximize Access Coverage

Notable Arborists
02. 10. 2007
0 views

Notable Arborists

INDEX OF SEGREGATION
07. 12. 2007
0 views

INDEX OF SEGREGATION

wilhelm2
04. 01. 2008
0 views

wilhelm2

FV1 day1
07. 01. 2008
0 views

FV1 day1

berdai
23. 10. 2007
0 views

berdai

weddings
11. 12. 2007
0 views

weddings

McDowell
29. 10. 2007
0 views

McDowell

usa jl
13. 11. 2007
0 views

usa jl

Construccion de un NOM
24. 10. 2007
0 views

Construccion de un NOM

TuLiP Overview
04. 09. 2007
0 views

TuLiP Overview

tulip
04. 09. 2007
0 views

tulip

HawaiiPresentation
17. 12. 2007
0 views

HawaiiPresentation

ompi tm cas 04 5
23. 10. 2007
0 views

ompi tm cas 04 5

Chapter12
03. 10. 2007
0 views

Chapter12

asian inc
29. 10. 2007
0 views

asian inc

Mat Prod L10
14. 02. 2008
0 views

Mat Prod L10

featurefilm
17. 10. 2007
0 views

featurefilm

EJ Genetic Research
24. 02. 2008
0 views

EJ Genetic Research

badagliacco
24. 02. 2008
0 views

badagliacco

Science and Warfare Lecture 1
26. 02. 2008
0 views

Science and Warfare Lecture 1

AHCIVI 1
27. 02. 2008
0 views

AHCIVI 1

student pressentation mngn
07. 11. 2007
0 views

student pressentation mngn

trucks 4 comm
28. 02. 2008
0 views

trucks 4 comm

2007EMSVaccinationTr aining
10. 03. 2008
0 views

2007EMSVaccinationTr aining

Mehta diving and the environment
11. 03. 2008
0 views

Mehta diving and the environment

Perform Basis06 A0 en last
25. 03. 2008
0 views

Perform Basis06 A0 en last

wttcsantiago2007
26. 03. 2008
0 views

wttcsantiago2007

Living on Mars
07. 04. 2008
0 views

Living on Mars

lect22 handout
15. 10. 2007
0 views

lect22 handout

pedagogy
04. 09. 2007
0 views

pedagogy

FEE dev IHEP
31. 08. 2007
0 views

FEE dev IHEP

Rong Gen Cai
01. 12. 2007
0 views

Rong Gen Cai

mps break st louis
18. 06. 2007
0 views

mps break st louis

Moving on with Statistics
19. 06. 2007
0 views

Moving on with Statistics

Module 2 TAKS05
19. 06. 2007
0 views

Module 2 TAKS05

microsoft office overview
19. 06. 2007
0 views

microsoft office overview

Math in Middle School
19. 06. 2007
0 views

Math in Middle School

Math Concordance Show
19. 06. 2007
0 views

Math Concordance Show

Mary George
19. 06. 2007
0 views

Mary George

Lower Division
19. 06. 2007
0 views

Lower Division

Lecture Amiens
19. 06. 2007
0 views

Lecture Amiens

lady adalovelace
19. 06. 2007
0 views

lady adalovelace

Kelm
31. 08. 2007
0 views

Kelm

Oct06 CAC Presentation1
18. 06. 2007
0 views

Oct06 CAC Presentation1

NLI 0460
18. 06. 2007
0 views

NLI 0460

nicholas
18. 06. 2007
0 views

nicholas

NCLB Highly Qualified
18. 06. 2007
0 views

NCLB Highly Qualified

NCLB An dE Rate1029
18. 06. 2007
0 views

NCLB An dE Rate1029

MWR 07073
18. 06. 2007
0 views

MWR 07073

mtts product show
18. 06. 2007
0 views

mtts product show

OMSC
18. 06. 2007
0 views

OMSC

PACA 16 de agosto
22. 10. 2007
0 views

PACA 16 de agosto

dh firenze
19. 10. 2007
0 views

dh firenze

gridpp16 servicechallenges
24. 10. 2007
0 views

gridpp16 servicechallenges

lwi
19. 06. 2007
0 views

lwi

AnLiu IDAR07 nocomment
12. 10. 2007
0 views

AnLiu IDAR07 nocomment

VoIPSlides
12. 03. 2008
0 views

VoIPSlides

3 Russia 05
26. 10. 2007
0 views

3 Russia 05

Lynnand Marsha
19. 06. 2007
0 views

Lynnand Marsha

07 0314 k ahuja
28. 09. 2007
0 views

07 0314 k ahuja

PresJMorales
22. 10. 2007
0 views

PresJMorales

Math TEKS K5
19. 06. 2007
0 views

Math TEKS K5

me579 16 internetMC
15. 11. 2007
0 views

me579 16 internetMC

Briars
04. 09. 2007
0 views

Briars

Esm Juny 05 IESE tcm48 42493
01. 10. 2007
0 views

Esm Juny 05 IESE tcm48 42493

CESARE PACIOTTI
10. 10. 2007
0 views

CESARE PACIOTTI

kep engl2007
15. 10. 2007
0 views

kep engl2007

LCG Switzerland Phase 2
19. 10. 2007
0 views

LCG Switzerland Phase 2

stoddart
06. 03. 2008
0 views

stoddart

Ch Kor Symp00
13. 10. 2007
0 views

Ch Kor Symp00

xps seminar jan e
19. 06. 2007
0 views

xps seminar jan e

soda3
03. 01. 2008
0 views

soda3

nys status Report 2006 2007
18. 06. 2007
0 views

nys status Report 2006 2007

JOSB
21. 11. 2007
0 views

JOSB

raffo phdthesis
07. 10. 2007
0 views

raffo phdthesis

parolari
03. 01. 2008
0 views

parolari

bailey
23. 10. 2007
0 views

bailey